Characterization of Kinetic Binding Properties of Unlabeled Ligands via a Preincubation Endpoint Binding Approach.

about

Characterization of Kinetic Binding Properties of Unlabeled Ligands via a Preincubation Endpoint Binding Approach.

Item

http://www.wikidata.org/entity/Q50632046

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh-hant

name

Characterization of Kinetic Bi ...... ion Endpoint Binding Approach.

@en

Characterization of Kinetic Bi ...... ion Endpoint Binding Approach.

@nl

type

Item

label

Characterization of Kinetic Bi ...... ion Endpoint Binding Approach.

@en

Characterization of Kinetic Bi ...... ion Endpoint Binding Approach.

@nl

prefLabel

Characterization of Kinetic Bi ...... ion Endpoint Binding Approach.

@en

Characterization of Kinetic Bi ...... ion Endpoint Binding Approach.

@nl

P1476

Characterization of Kinetic Bi ...... ion Endpoint Binding Approach.

@en

P2093

Kazumasa Ogawa

http://www.w3.org/2001/XMLSchema#string

Masaharu Nakayama

http://www.w3.org/2001/XMLSchema#string

Yuji Shimizu

http://www.w3.org/2001/XMLSchema#string

P2860

Long-lasting target binding and rebinding as mechanisms to prolong in vivo drug action

Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction

Pharmacological characterization of GSK1004723, a novel, long-acting antagonist at histamine H(1) and H(3) receptors

Slow antagonist dissociation and long-lasting in vivo receptor protection.

Drug-target residence time and its implications for lead optimization.

Drug-target residence time--a case for G protein-coupled receptors.

Biochemical characterization of smoothened receptor antagonists by binding kinetics against drug-resistant mutant.

Structure-kinetic relationships--an overlooked parameter in hit-to-lead optimization: a case of cyclopentylamines as chemokine receptor 2 antagonists.

Dual-point competition association assay: a fast and high-throughput kinetic screening method for assessing ligand-receptor binding kinetics.

Multifaceted approach to determine the antagonist molecular mechanism and interaction of ibodutant ([1-(2-phenyl-1R-[[1-(tetrahydropyran-4-ylmethyl)-piperidin-4-ylmethyl]-carbamoyl]-ethylcarbamoyl)-cyclopentyl]-amide) at the human tachykinin NK2 rec

P304

729-737

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/1087057116652065

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-06-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27270099

http://www.w3.org/2001/XMLSchema#string